Related Experiment Video
Updated: Jul 18, 2026
14:49
Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration
Published on: September 29, 2018
Viscosupplementation therapy for osteoarthritis
Stephen F Brockmeier1, Benjamin S Shaffer
1Department of Orthopaedic Surgery, Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC 20007, USA.
Sports Medicine and Arthroscopy Review
|December 1, 2006
Summary
Hyaluronic acid injections for osteoarthritis offer pain relief and are safe, but placebo effects and bias obscure true efficacy. More research is needed to confirm disease-modifying potential.
Area of Science:
- Orthopedics
- Rheumatology
- Biomedical Engineering
Background:
- Osteoarthritis (OA) management often involves intra-articular therapies.
- Hyaluronic acid (HA) injections are a common viscosupplementation treatment for OA symptoms.
Purpose of the Study:
- To review the development and clinical outcomes of viscosupplementation therapy for osteoarthritis.
- To evaluate the efficacy and safety of intra-articular hyaluronic acid in OA patients.
Main Methods:
- Review of basic science research on exogenous hyaluronic acid.
- Analysis of clinical data regarding viscosupplementation safety and pain relief.
- Assessment of evidence for disease-modifying potential.
Main Results:
- Viscosupplementation with hyaluronic acid is generally safe for OA.
- Clinical data suggest some therapeutic efficacy for pain relief.
- Robust placebo effects and industry bias complicate outcome assessment.
- Definitive evidence for disease modification is currently lacking.
Conclusions:
- Intra-articular hyaluronic acid is an accepted option for symptomatic OA management.
- Further research is required to clarify the true clinical benefits and potential disease-modifying effects of HA viscosupplementation.
Related Concept Videos
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...